ISO 11137-1:2006
|
Sterilization of health care products Radiation Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices
|
ISO 10993-3:2014
|
Biological evaluation of medical devices — Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
|
ISO 10993-4:2017
|
Biological evaluation of medical devices — Part 4: Selection of tests for interactions with blood
|
ISO 11607-2:2006
|
Packaging for terminally sterilized medical devices Part 2: Validation requirements for forming, sealing and assembly processes
|
ISO 14160:2011
|
Sterilization of health care products Liquid chemical sterilizing agents for single-use medical devices utilizing animal tissues and their derivatives Requirements for characterization, development, validation and routine control of a sterilization process for medical devices
|
ISO 14155-2:2003
|
Clinical investigation of medical devices for human subjects Part 2: Clinical investigation plans
|
ISO 13779-1:2008
|
Implants for surgery Hydroxyapatite Part 1: Ceramic hydroxyapatite
|
ISO 14937:2009
|
Sterilization of health care products General requirements for characterization of a sterilizing agent and the development, validation and routine control of a sterilization process for medical devices
|
ISO 10993-2:2006
|
Biological evaluation of medical devices — Part 2: Animal welfare requirements
|
ISO 22442-1:2015
|
Medical devices utilizing animal tissues and their derivatives Part 1: Application of risk management
|
ISO 11135-1:2007
|
Sterilization of health care products Ethylene oxide Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices
|
ISO 14630:2012
|
Non-active surgical implants — General requirements
|
ISO/TR 14283:2004
|
Implants for surgery Fundamental principles
|
EN 1041:2008+A1:2013
|
Information supplied by the manufacturer of medical devices
|
ISO 10993-10:2010
|
Biological evaluation of medical devices Part 10: Tests for irritation and skin sensitization
|
ISO 13408-1:2008
|
Aseptic processing of health care products — Part 1: General requirements
|
ISO 1942:2009
|
Dentistry Vocabulary
|
ISO 10993-11:2017
|
Biological evaluation of medical devices — Part 11: Tests for systemic toxicity
|
ISO 10993-12:2012
|
Biological evaluation of medical devices Part 12: Sample preparation and reference materials
|
ISO 10993-7:2008
|
Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals
|
ISO 10993-17:2002
|
Biological evaluation of medical devices — Part 17: Establishment of allowable limits for leachable substances
|
ISO 10993-1:2009
|
Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process
|
ISO 22442-2:2015
|
Medical devices utilizing animal tissues and their derivatives Part 2: Controls on sourcing, collection and handling
|
ISO 10993-9:2009
|
Biological evaluation of medical devices Part 9: Framework for identification and quantification of potential degradation products
|
ISO 22442-3:2007
|
Medical devices utilizing animal tissues and their derivatives — Part 3: Validation of the elimination and/or inactivation of viruses and transmissible spongiform encephalopathy (TSE) agents
|
ISO 14971:2007
|
Medical devices Application of risk management to medical devices
|
EN 980:2008
|
Symbols for use in the labelling of medical devices
|
ISO 10993-6:2016
|
Biological evaluation of medical devices Part 6: Tests for local effects after implantation
|
ISO 17665-1:2006
|
Sterilization of health care products — Moist heat — Part 1: Requirements for the development, validation and routine control of a sterilization process for medical devices
|
ISO 15223:2000
|
Medical devices Symbols to be used with medical device labels, labelling and information to be supplied
|